Kaneka Medical America
Open enrollment across a mixed-phase pipeline
According to ClinicalTrials.gov-derived indexes, Kaneka Medical America sits in the upper quartile of US sponsors by registered trial count (#2,411 of 15,742 sponsors by registered trial count).
Kaneka Medical America: 5 sponsored US clinical trials, 3 recruiting.
Kaneka Medical America sponsors 5 registered US clinical trials on ClinicalTrials.gov, 3 of them currently recruiting. The most-studied condition in this pipeline is Focal Segmental Glomerulosclerosis, with 2 trials.
Upper-quartile sponsor footprint
Kaneka Medical America sits in the upper quartile of the sponsor corpus (#2,411 of 15,742 sponsors by registered trial count) - denser than most sponsors, still short of the top-decile hubs.
Open and recent trials
5 total, page 1 of 1
Post Approval Study for Treatment of Drug-resistant Adult and Pediatric Primary FSGS Using the LIPOSORBER® LA-15 System
NCT04065438
Post Approval Study of Lixelle for the Treament of Dialysis-Related Amyloidosis
NCT02952144
Post Approval Study of Liposorber LA-15 System for the Treatment of Focal Segmental Glomerulosclerosis in Children
NCT02235857
Kaneka Endovascular Embolization and Protection
NCT05563051
Prospective Multi-center Single Arm Study for Subjects With Chronic Subdural Hematoma Treated With i-ED COILs, Either Alone or in Combination With Burr-holes or Mini-craniotomy
NCT07214623
Therapeutic Areas
What is open in the Kaneka Medical America pipeline
3 recruiting of 5 indexed (60% open).
Phase labels are sparse on this sponsor index, so phase mix is not charted here.
Top condition: Focal Segmental Glomerulosclerosis (2 trials), 2 others listed.
How open-pipeline share is computed
Recruiting share is recruiting_count divided by trial_count for this sponsor in the public registry export. Status can change between pulls; treat the figure as a research-attention snapshot, not product availability.
Kaneka Medical America: open-pipeline peers nationwide
Peers matched on 5 registered trials and 60% open enrollment, not the therapeutic-area sidebar.
Kaneka Medical America sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together.
Sponsors near 5 trials (± recruiting share)
- 4YouandMe · 5 trials · 0% recruiting
- Abbott Rapid Dx · 5 trials · 0% recruiting
- Access Business Group · 5 trials · 0% recruiting
- Acera Surgical · 5 trials · 20% recruiting
Sponsors near 60% open enrollment (± trial volume)
- Alaska Native Tribal Health Consortium · 60% recruiting · 5 trials
- Anwaar Saeed · 60% recruiting · 5 trials
- Autolus Limited · 60% recruiting · 5 trials
- Beam Therapeutics · 60% recruiting · 5 trials
Related
What to do with this Kaneka Medical America page
5 registered trials is a research-attention snapshot, not an endorsement of Kaneka Medical America or any single study.
- 3 of Kaneka Medical America's trials are currently recruiting, check each one's own eligibility criteria before contacting a site. Browse recruiting trials
- Focal Segmental Glomerulosclerosis is the condition Kaneka Medical America studies most, compare against other sponsors active in the same condition before evaluating a specific study. See Focal Segmental Glomerulosclerosis trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. Kaneka Medical America pipeline card: 5 registered trials from official public datasets. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.